CBD of Denver, Inc. specializes in the production and distribution of CBD-based products, primarily targeting the health and wellness sector. The company operates in the U.S. market, leveraging its unique formulations and proprietary extraction methods to differentiate itself in a competitive landscape.
CBD of Denver generates revenue through the sale of a diverse range of CBD products, focusing on quality and compliance with regulatory standards. Its competitive advantage lies in its proprietary extraction technology, which enhances product purity and efficacy, allowing for premium pricing.
Changes in federal regulations regarding CBD and hemp-derived products
Consumer demand trends for health and wellness products
Partnerships with retailers for product distribution
Market share changes in the CBD sector
Regulatory changes impacting the legality and marketing of CBD products
Market saturation and increased competition in the CBD space
Emergence of larger, well-capitalized competitors entering the CBD market
Potential for price wars as new entrants drive down margins
Negative net margin indicating ongoing operational losses
Low current ratio suggesting liquidity concerns
moderate - The demand for health and wellness products is somewhat resilient during economic downturns, but discretionary spending can impact sales.
Minimal impact as the company does not rely heavily on debt financing due to its negative debt/equity ratio.
minimal - The company operates with a negative debt/equity ratio, indicating low reliance on credit.
growth - Investors seeking exposure to the burgeoning CBD market and health trends.
high - The stock has shown significant price fluctuations, evidenced by a 37.5% decline over the past year.